157 related articles for article (PubMed ID: 17502923)
1. Expression of genes encoding mitochondrial proteins can distinguish nonalcoholic steatosis from steatohepatitis.
Bragoszewski P; Habior A; Walewska-Zielecka B; Ostrowski J
Acta Biochim Pol; 2007; 54(2):341-8. PubMed ID: 17502923
[TBL] [Abstract][Full Text] [Related]
2. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease.
Younossi ZM; Baranova A; Ziegler K; Del Giacco L; Schlauch K; Born TL; Elariny H; Gorreta F; VanMeter A; Younoszai A; Ong JP; Goodman Z; Chandhoke V
Hepatology; 2005 Sep; 42(3):665-74. PubMed ID: 16116632
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
Tiniakos DG
Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease.
Mendez-Sanchez N; Zamora-Valdes D; Pichardo-Bahena R; Barredo-Prieto B; Ponciano-Rodriguez G; Bermejo-Martínez L; Chavez-Tapia NC; Baptista-González HA; Uribe M
Liver Int; 2007 Mar; 27(2):215-9. PubMed ID: 17311616
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.
Crespo J; Cayón A; Fernández-Gil P; Hernández-Guerra M; Mayorga M; Domínguez-Díez A; Fernández-Escalante JC; Pons-Romero F
Hepatology; 2001 Dec; 34(6):1158-63. PubMed ID: 11732005
[TBL] [Abstract][Full Text] [Related]
6. Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis.
Sreekumar R; Rosado B; Rasmussen D; Charlton M
Hepatology; 2003 Jul; 38(1):244-51. PubMed ID: 12830008
[TBL] [Abstract][Full Text] [Related]
7. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.
Younossi ZM; Gorreta F; Ong JP; Schlauch K; Del Giacco L; Elariny H; Van Meter A; Younoszai A; Goodman Z; Baranova A; Christensen A; Grant G; Chandhoke V
Liver Int; 2005 Aug; 25(4):760-71. PubMed ID: 15998427
[TBL] [Abstract][Full Text] [Related]
8. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
[TBL] [Abstract][Full Text] [Related]
9. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
Konopelska S; Kienitz T; Hughes B; Pirlich M; Bauditz J; Lochs H; Strasburger CJ; Stewart PM; Quinkler M
Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
[TBL] [Abstract][Full Text] [Related]
10. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
McCullough AJ
Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
[TBL] [Abstract][Full Text] [Related]
12. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of nonalcoholic steatohepatitis (NASH).
Ma X; Li Z
Chin J Dig Dis; 2006; 7(1):7-11. PubMed ID: 16412031
[TBL] [Abstract][Full Text] [Related]
14. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease.
Komatsu M; Yazaki M; Tanaka N; Sano K; Hashimoto E; Takei Y; Song YZ; Tanaka E; Kiyosawa K; Saheki T; Aoyama T; Kobayashi K
J Hepatol; 2008 Nov; 49(5):810-20. PubMed ID: 18620775
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic steatohepatitis: clinicopathological profile.
Amarapurkar DN; Amarapurkar AD
J Assoc Physicians India; 2000 Mar; 48(3):311-3. PubMed ID: 11229116
[TBL] [Abstract][Full Text] [Related]
16. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional networks in a rat model for nonalcoholic fatty liver disease: a microarray analysis.
Sharma MR; Polavarapu R; Roseman D; Patel V; Eaton E; Kishor PB; Nanji AA
Exp Mol Pathol; 2006 Dec; 81(3):202-10. PubMed ID: 16949573
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
[TBL] [Abstract][Full Text] [Related]
19. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
[TBL] [Abstract][Full Text] [Related]
20. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.
Chen C; Schmilovitz-Weiss H; Liu XE; Pappo O; Halpern M; Sulkes J; Braun M; Cohen M; Barak N; Tur-Kaspa R; Vanhooren V; Van Vlierberghe H; Libert C; Contreras R; Ben-Ari Z
J Proteome Res; 2009 Feb; 8(2):463-70. PubMed ID: 19140676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
